Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cavitation Technologies (CVAT) EBITDA (2016 - 2025)

Cavitation Technologies' EBITDA history spans 16 years, with the latest figure at -$474000.0 for Q4 2025.

  • On a quarterly basis, EBITDA fell 58.53% to -$474000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.2 million, a 769.49% decrease, with the full-year FY2025 number at -$987000.0, down 325.34% from a year prior.
  • EBITDA hit -$474000.0 in Q4 2025 for Cavitation Technologies, down from -$249000.0 in the prior quarter.
  • Over the last five years, EBITDA for CVAT hit a ceiling of $369000.0 in Q2 2024 and a floor of -$480000.0 in Q2 2021.
  • Historically, EBITDA has averaged -$153850.0 across 5 years, with a median of -$231000.0 in 2025.
  • The widest YoY moves for EBITDA: up 249.33% in 2024, down 2035.71% in 2024.
  • Tracing CVAT's EBITDA over 5 years: stood at -$438000.0 in 2021, then skyrocketed by 34.47% to -$287000.0 in 2022, then skyrocketed by 95.12% to -$14000.0 in 2023, then plummeted by 2035.71% to -$299000.0 in 2024, then crashed by 58.53% to -$474000.0 in 2025.
  • Business Quant data shows EBITDA for CVAT at -$474000.0 in Q4 2025, -$249000.0 in Q3 2025, and -$234000.0 in Q2 2025.